Hi Abro,Company expected only limited number of approval for...

Hi Abro,Company expected only limited number of approval for tissue repair and FDA given more number of indications than company expected.Current margin is 81 and once RECELL GO get approval it will move to 90 percentage.RECELL GO is going to be a fully automatic device,in this scenario any medically professional personal can follow the instructions and use this product without much training.So international expansion will be much less expensive than anyone thinking about it.I have an exit point and in my calculation that is 8.50-9 AUS dollars,if it’s so bullish then I am happy to take anything more than 10 dollars.That we will see in short time and better keep it Abro.Lots of good announcements will drop in before xmas , Australian sale partnership,Japanese approval for soft tissue,international expansion plan,break even the sale in 4th quarter and there is a chance to increase the guidance again for 4th quarter,etc….enjoy your weekend…